Blood test may predict brain fog in prostate cancer treatment
NCT ID NCT05820932
First seen Oct 31, 2025 · Last updated May 05, 2026 · Updated 30 times
Summary
This study looks at whether a simple blood test can predict memory and thinking problems in men with prostate cancer who are receiving hormone therapy (ADT). Researchers will track 32 men over time, testing their memory and measuring a blood marker linked to Alzheimer's risk. The goal is to find a low-cost, non-invasive way to identify who might experience cognitive decline during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.